Clinical Trial Update: Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial of a Favrille vaccine combined with GM-CSF for progressive Non-Hodgkin lymphoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Favrille vaccine
• GM-CSF (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Favrille | Conditions: Lymphoma | Phase 2 | Status: TERMINATED